Efficacy News and Research

RSS
Sanofi-aventis announces study results comparing efficacy of Lantus to detemir

Sanofi-aventis announces study results comparing efficacy of Lantus to detemir

SATAI invests $1.045 million in Azaya Therapeutics

SATAI invests $1.045 million in Azaya Therapeutics

Plexxikon commences patient dosage in PLX4032 trials for metastatic melanoma

Plexxikon commences patient dosage in PLX4032 trials for metastatic melanoma

AMS’ products restore patient's pelvic health and their quality of life

AMS’ products restore patient's pelvic health and their quality of life

Michelle’s Miracle raises $750,000 in its first tranche of Series A funding

Michelle’s Miracle raises $750,000 in its first tranche of Series A funding

pSivida reports interim results of human PK study of Iluvien

pSivida reports interim results of human PK study of Iluvien

Synta commences Phase 1/2 clinical study of novel Hsp90 inhibitor in hematologic malignancies

Synta commences Phase 1/2 clinical study of novel Hsp90 inhibitor in hematologic malignancies

Acrux reports Phase III trial results evaluating AXIRON for testosterone deficiency

Acrux reports Phase III trial results evaluating AXIRON for testosterone deficiency

Spectranetics seeks FDA clearance for treating in-stent restenosis in the legs

Spectranetics seeks FDA clearance for treating in-stent restenosis in the legs

Repros Therapeutics receives further clarification on the Full Clinical Hold status of Proellex

Repros Therapeutics receives further clarification on the Full Clinical Hold status of Proellex

Journal publishes Hythiam's PROMETA treatment program results

Journal publishes Hythiam's PROMETA treatment program results

Januvia in combination with metformin or taken alone lowers blood sugar

Januvia in combination with metformin or taken alone lowers blood sugar

NovoCure initiates newly-diagnosed GBM clinical trial

NovoCure initiates newly-diagnosed GBM clinical trial

International Medica Foundation sponsors rotavirus vaccine trial in Ghana

International Medica Foundation sponsors rotavirus vaccine trial in Ghana

NIH awards DiscoveryBioMed a Phase 2 SBIR grant for research on hypertension and cystic fibrosis

NIH awards DiscoveryBioMed a Phase 2 SBIR grant for research on hypertension and cystic fibrosis

Halozyme Therapeutics announces Phase 1 clinical study to assess three insulin analogs

Halozyme Therapeutics announces Phase 1 clinical study to assess three insulin analogs

European Commission grants conditional marketing authorization for Gilead's Cayston

European Commission grants conditional marketing authorization for Gilead's Cayston

Preliminary results from procedural review of Menaflex released by the FDA

Preliminary results from procedural review of Menaflex released by the FDA

Phase 2 clinical trial results of IMO-2055 announced

Phase 2 clinical trial results of IMO-2055 announced

FDA grants accelerated approval for Allos Therapeutics’ FOLOTYN

FDA grants accelerated approval for Allos Therapeutics’ FOLOTYN

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.